Research Focus
Dr. Feng Li is a staff scientist in the Diako Lab at Texas Biomedical Research Institute, where his research centers on defining the roles of DNA damage factors in cancer and retroviral infection. Dr. Li is a molecular biologist with 7+ years of NIH experience in transposable elements and HIV biology, pioneering new strategies for HIV cure via CRISPR. His expertise bridges quantitative biology, genomics, and virus-host interaction, contributing to new insights on genomic instability and mechanisms linking HIV infection and tumorigenesis. Dr. Li’s scholarly impact is demonstrated through numerous influential publications and citations, including works in Nucleic Acids Research and Science Advances.